By Dr Alan Nafiiev (CEO and Founder of Receptor.AI)2025-10-03T09:00:28
Dr Alan Nafiiev evaluates template-based, docking and template-free approaches to PPI prediction, highlighting how AI can enhance structural accuracy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
2024-01-24T12:52:38
Sponsored by BellBrook Labs
Site powered by Webvision Cloud